# Observational Study of the Long-term Effect of Latanoprost in Normal Tension Glaucoma

> **NCT01209624** · — · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 902 (actual)

## Conditions studied

- Low Tension Glaucoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01209624
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 902 (ACTUAL)
- **Last updated:** 2021-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01209624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01209624, "Observational Study of the Long-term Effect of Latanoprost in Normal Tension Glaucoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01209624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*